Skip to main content
Signal8

Evelo Biosciences, Inc. (EVLO)

Evelo Biosciences, Inc. is a biotechnology firm dedicated to identifying and advancing oral biologic therapies for various inflammatory conditions and oncological diseases. Its pipeline includes EDP1815, a whole-microbe compound designed to address inflammatory ailments, currently undergoing Phase 2 clinical trials for conditions such as psoriasis and atopic dermatitis, and also being evaluated for the hyperinflammatory reaction associated with COVID-19. Additional developments include EDP1867, an inactivated oral biologic in Phase 1b for inflammatory diseases; EDP2939, an investigational oral biologic based on extracellular vesicles targeting inflammatory diseases; and EDP1908, a drug candidate focused on cancer. Established in 2014, Evelo Biosciences, Inc. operates from its headquarters in Cambridge, Massachusetts.

Sector: Biotechnology

Industry: Biotechnology

Evelo Biosciences, Inc. logo

Evelo Biosciences, Inc.

OTC:EVLOHealthcare
CLOSED
Mkt Cap-
EV-
Float18.9M
O/S37.97M
VOL1K sh
$ Vol$0
RVOL1.00×
Inst Own-
SI<0.1%
Net Cash/Sh-
EarningsNov 17 · Today
Dilution
Short interest (FINRA)
0.0%
Oct 30 (18d)

Float 18.90M · FMP free float

6.7K
Oct 30 (18d)prev 6.7K– 0.0%
42.09
Oct 30 (18d)prev 1.00▲ 4109.0%
Borrow (IBKR)

The cost to borrow EVLO shares for a short sale and how many IBKR has available, from IBKR's lendable-stock file, refreshed through the session.

IBKR borrow fee and availability is included in Signal8 ProUpgrade to Pro · $40.67/mo billed annually
Off-exchange & settlement
24
Jul 6 (134d)prev 24– 0.0%
Price, short interest & fails to deliver
Short interest · today's share basis23 settlements
Fails to deliver4 settlement dates
Latest short interest settlements (today's share basis)
DateShares short
Oct 30, 20266.7K sh
Oct 15, 20266.7K sh
Sep 30, 20266.7K sh
Sep 15, 20266.7K sh
Aug 31, 20266.7K sh
Latest fails to deliver
DateShares failed
Jul 6, 202624 sh
Jul 2, 202624 sh
Jul 1, 202624 sh
Jun 30, 202624 sh

A stock split executed inside this window; every settlement plotted has been carried onto today’s share basis, so the line does not step at the split.

The three panels share one date axis, so a point's position is its date; each has its own value axis. Short interest is plotted on today's share basis, so the line does not step where a split does.

Off-exchange short volume

FINRA publishes no off-exchange short volume for this symbol.

ATS venues (dark pools)

FINRA's weekly alternative trading system (dark pool) volume for EVLO: the share of off-exchange volume that traded on an ATS, and each venue by shares and trades.

The ATS venue breakdown is included in Signal8 ProUpgrade to Pro · $40.67/mo billed annually

As of the Oct 30, 2026 FINRA settlement, 6,734 EVLO shares were sold short (0.04% of a 18.90M-share float, 42.09 days to cover).